Funded Biotechnology Startups in Amsterdam
Among the 13 most recent biotech funding entries in Amsterdam, the largest disclosed round is UniQure’s $259M on 2026-06-23, which dwarfs all other disclos…
Among the 13 most recent biotech funding entries in Amsterdam, the largest disclosed round is UniQure’s $259M on 2026-06-23, which dwarfs all other disclosed amounts in the table (the next-highest disclosed is VectorY’s $138M on 2023-11-13). The disclosed amounts are mostly concentrated well below those top two figures, with several single-digit rounds such as RespiQ at $4M (2023-11-20) and PayEye at $4M (2022-10-20).
The date range spans 2026-06-23 back to 2022-03-10, and there is a secondary cluster in late 2023: VectorY ($138M, 2023-11-13), RespiQ ($4M, 2023-11-20), and Lapsi Health ($4M, 2023-11-10) all land within about a week of each other. Stage disclosures are dominated by “Series Unknown” entries, with 6 of 13 rows labeled Series Unknown, alongside 2 undisclosed amounts.
Most recent rounds
13 shownRelated listings
Frequently asked
What stands out as an outlier in Amsterdam biotech rounds, based on disclosed sizes?
UniQure’s $259M on 2026-06-23 is the only disclosed round above $100M; it materially outweighs the next-largest disclosed amount, VectorY’s $138M on 2023-11-13.
How much of the recent activity is concentrated in a tight late-2023 window?
Three disclosed rounds cluster in mid-to-late November 2023: Lapsi Health closes at $4M on 2023-11-10, VectorY at $138M on 2023-11-13, and RespiQ at $4M on 2023-11-20—each within roughly 10 days.
Are “Series Unknown” classifications dominating this Amsterdam biotech list?
Yes: 6 of 13 rows are labeled “Series Unknown” (including Leyden Labs on 2026-06-25 at $45M and Confocal.nl on 2024-10-17 at $5M). Separately, 2 rows show an “undisclosed” amount (Scinvivo on 2025-10-28 and Genewity B.V. on 2023-06-23).
Which disclosed stages appear repeatedly, and where do the largest disclosed rounds sit among them?
Beyond Series Unknown, the list includes Seed (Lapsi Health at $4M on 2023-11-10; PayEye at $4M on 2022-10-20) and Series A (VectorY at $138M on 2023-11-13; Scenic Biotech at $31M on 2022-03-10). The largest disclosed rounds in the table occur in Series Unknown (UniQure $259M on 2026-06-23) and in Series A (VectorY $138M on 2023-11-13).
Which entries represent the smallest disclosed amounts, and do they cluster in time?
The smallest disclosed amount is $4M, appearing for RespiQ (2023-11-20, $4M) and Lapsi Health (2023-11-10, Seed, $4M), and again for PayEye (2022-10-20, Seed, $4M). Two of these $4M rounds sit in late 2023 close together (Lapsi Health and RespiQ).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.